Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 September 2023 | Story Valentino Ndaba | Photo Quinter Onyango
High Court Tour
The Free State High Court hosted a Women's Month educational tour for UFS female students.

"It is significant to reflect that it was just more than 100 years since women were allowed to practice law. The first female legal practitioners being admitted in the early 1920s. A celebration of Women's Month acknowledges the many victories for equality and social justice that women practising in the legal profession have contributed and continue to contribute," said Dr Anthea-Lee September-Van Huffel, Private Law Lecturer in the University of the Free State (UFS) Faculty of Law, as she reflected on the importance of commemorating Women's Month.

To conclude the celebration, the faculty collaborated with the Free State High Court to organise a tour, affording a group of UFS female students the opportunity to immerse themselves in the practical aspects of civil litigation by observing court proceedings in the Free State High Court.

A glimpse into the legal world

The students engaged with judges, advocates, and attorneys, addressing challenges confronting the legal profession, including issues related to mental health post-qualification. Judge Nokuthula Daniso emphasised during the proceedings, "A career in the legal profession is highly demanding. Your passion, proficiency, and diligence are your armour."

Salomie Kichele, a third-year Law student, was among the participants of the tour. She described the experience as the highlight of her year, saying, "Observing the intricacies of the legal system, from courtroom processes to the dynamics between judges, attorneys, and others, was truly fascinating. However, what truly stood out was gaining access to the judge's chamber, a privilege that is usually restricted. Being able to engage the judge with questions about her journey to becoming a judge, especially as a woman, was inspirational. Being inside the judge's chamber, surrounded by South African law books, highlighted the level of expertise required of our judges when dealing with cases. This experience further motivated me to continue nurturing my passion for reading."

Bridging the Gap Between Theory and Practice

For Kichele, this exposure to the High Court and interaction with judges, advocates, and attorneys provided clarity regarding the expectations placed upon her as a future legal practitioner. It bridged the gap between theoretical knowledge acquired in the classroom and the practical application of the law. By witnessing real cases and observing legal professionals in action, Law students gain a deeper understanding of the legal system's intricacies and the nuances of courtroom dynamics.

"Such exposure helped me identify the specialisation I would like to pursue in the legal field and fuelled my determination to pursue it. Furthermore, being within the High Court environment highlighted the need for more female judges. Experiencing this can serve as a motivating force for women aspiring to become judges one day," Kichele added. 

Bloemfontein's legal legacy

The UFS Faculty of Law enjoys an advantageous location in Bloemfontein, renowned as a central hub for numerous high-profile legal cases, primarily because it houses the Supreme Court of Appeal. Furthermore, the faculty takes pride in the fact that several of its academic staff members have, over the years, served as acting judges in the Bloemfontein High Court. Consequently, the Faculty of Law remains dedicated to nurturing and fortifying its ties within the legal profession. 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept